Local Institution - 0178

Nanchang, Jiangxi 330006

1 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4) — Recruiting now
• A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery — Completed